The GABAB receptor positive allosteric modulator ASP8062 reduces operant alcohol self-administration in male and female Sprague Dawley rats
Authors:
- 6 July 2021
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 238 (9) , 2587-2600
Abstract
Rationale Pre-clinical evidence implicates the GABAergic system in mediating the reinforcing effects of alcohol and offers a therapeutic target for alcohol use disorder (AUD). The orthosteric GABAB receptor agonist baclofen decreases alcohol self-administration in animals and alcohol use in humans; however side effects limit its utility. Pre-clinical evidence shows positive allosteric GABAB receptor modulators also decrease alcohol self-administration without untoward side effects. Objectives We assessed the impact of the novel GABAB-positive allosteric modulator ASP8062 and baclofen on operant alcohol self-administration and their potential non-specific effects. Methods The effects of ASP8062 (1 − 10 mg/kg, PO) and baclofen (0.3 − 3 mg/kg, IP) were evaluated in male and female rats lever pressing for alcohol (10%, w/v) under a fixed ratio 2 schedule of reinforcement. On the fourth consecutive day of vehicle, ASP8062 or baclofen administration, active and inactive lever presses, reinforcers earned, head entries, and estimated alcohol consumed were analyzed. Locomotor activity was assessed in separate groups of rats following dosing. Results Both ASP8062 and baclofen decreased alcohol self-administration and amount consumed (g/kg) in male and female rats. ASP8062 decreased operant alcohol self-administration to a greater extent in male rats, whereas baclofen was more efficacious in female rats. ASP8062 did not alter locomotor activity in either sex, whereas baclofen (3.0 mg/kg) decreased activity in male rats yet (1.0 mg/kg) increased activity in female rats. Conclusions ASP8062 decreases alcohol reinforcement like baclofen but without non-specific effects which are influenced by sex. Results support further development of ASP8062 as a potential treatment for AUD in humans.Keywords
Funding Information
- Office of the Secretary of Defense (3-312-0215031-52745L)
This publication has 58 references indexed in Scilit:
- Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependenceProgress in Neurobiology, 2018
- The GABAB Positive Allosteric Modulator ADX71441 Attenuates Alcohol Self-Administration and Relapse to Alcohol Seeking in RatsNeuropsychopharmacology, 2017
- Sex Differences in Animal Models: Focus on AddictionPharmacological Reviews, 2016
- GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidenceFrontiers in Neuroscience, 2014
- Differential G-protein coupling to GABAB receptor in limbic areas of alcohol-preferring and -nonpreferring ratsEuropean Journal of Pharmacology, 2005
- Effect of Baclofen on Alcohol and Sucrose Self-Administration in RatsAlcohol, Clinical and Experimental Research, 2003
- Sex differences in the effects of baclofen on the acquisition of intravenous cocaine self-administration in ratsDrug and Alcohol Dependence, 2002
- Sex and Strain Differences in Ethanol Drinking: Effects of GonadectomyAlcohol, Clinical and Experimental Research, 2001
- Ability of Baclofen in Reducing Alcohol Intake and Withdrawal Severity: I???Preclinical EvidenceAlcohol, Clinical and Experimental Research, 2000
- Interactions between naloxone and GABA in the control of locomotor activity in the ratJournal of Neural Transmission, 1985